Clinical research generates immediate and strategic economic value

Clinical trials are a source of funding from outside the hospital that enables it to strengthen its infrastructure, recruit specialist staff, purchase equipment and improve processes. diariomedico.com Clinical trials are the primary source of evidence for determining the efficacy and safety of new medicines, and ensure that regulatory, clinical and funding decisions are based on […]

Asia is stepping up investment in the pharmaceutical sector to establish itself as a new global hub for healthcare innovation

Growth in the Asian market, biotechnology and digitalisation are attracting international capital to the regional pharmaceutical industry consalud.es Asia is establishing itself as one of the world’s leading hubs for pharmaceutical investment. An academic analysis published in the University of Oregon’s repository examines how economic growth, expansion of healthcare provision and technological advances are driving […]

Unresolved issues in medical science: Spain leads the way in clinical trials, but only 8 per cent reach primary care

Doctors and the industry are calling for a push to boost clinical research in healthcare centres in order to optimise treatments for the most common conditions and bring cutting-edge medicine closer to patients elmundo.es Jesús González, a GP at the Cabra Health Centre (Córdoba), highlights a paradox that exists in the field of clinical trials […]

ICON joins forces with Microsoft to revolutionise clinical trials using artificial intelligence

The Irish multinational will implement Microsoft Copilot and Azure to optimise the design of clinical trials and accelerate drug development consalud.es This week, the Irish company ICON, which specialises in contract research organisation (CRO) services, announced a technology partnership with Microsoft as part of its strategy to increase investment in artificial intelligence over the next […]

The pharmaceutical industry is warning Europe that it will lose investment if it does not pay more for innovative medicines

The EFPIA president points out that US pricing policy is putting pressure on the continent and warns that the sector will cut back on manufacturing and clinical trials if profit margins are reduced Consalud.es The president of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Stefan Oelrich, has issued a statement in which he […]

US speeds up clinical trials: the biotechnology industry calls on the FDA to standardise the drug approval process

Following the announcement of a plan to speed up clinical trials in the face of competition from China, the sector is calling for an end to the uncertainty and for the evaluation of new drugs to be standardised consalud.es The Biotechnology Innovation Organisation (BIO), the leading advocacy group for the biotechnology industry in the US, […]

Pharmaceutical innovation has seen its investment in Europe increase fivefold, with a profit of 66,000 million

A new study by the European Federation of Pharmaceutical Industries and Associations (EFPIA) shows that the introduction of new treatments frees up more than 57,000 hospital beds and generates net savings of 9,000 million euros in just one year consalud.es The European Federation of Pharmaceutical Industries and Associations (EFPIA) has taken a step forward in […]

Biomedical research in Spain: between leadership, bureaucratic red tape and the challenge of data management

The panel ‘Science for Life: Research in the Service of Health’ brought the 1st Impact Forum to a close, with the aim of understanding how innovation serves the public Tercera mesa del I Foro Impacto eldiario.es The ‘1st Impact Forum: Innovation with a Purpose’ event, organised by elDiario.es, concluded with a panel discussion that examined […]

Spain can take the decisive leap forward in biomedical research: from a scientific powerhouse to a global leader

The 19th Conference of Biomedical Research Technology Platforms brings together more than 200 representatives from public administrations, universities, patient groups and businesses in Barcelona Experts stress that Spain’s research ecosystem needs to continue making progress in cooperation, knowledge transfer and business development, with the aim of generating innovation that has an impact on patients’ health […]

The time taken to gain access to new medicines has fallen to 537 days, although this is still far from the 180-day limit set by the European Directive

The WAIT 2025 Report shows that Spanish patients have access to 69% of new medicines authorised in Europe, yet only 47% of these are available without restrictions In a geopolitical context of great uncertainty, predictability is a key factor in competitiveness. A process characterised by long and unpredictable timelines, opaque rules, or negotiations focused exclusively […]